产品详情
文献和实验
相关推荐
注册证号 :详询
英文名 :HT-1197
库存 :1x10^6/瓶
供应商 :上海酶研
肿瘤类型 :膀胱癌
细胞类型 :HT-1197
ATCC Number :详询
品系 :HT-1197
组织来源 :人膀胱癌细胞
相关疾病 :详询
物种来源 :人
免疫类型 :详询
细胞形态 :贴壁/悬浮
是否是肿瘤细胞 :是
器官来源 :人膀胱癌细胞
运输方式 :顺丰快递
年限 :5年
生长状态 :生长良好
规格 :瓶
HT-1197、HT-1197、HT-1197细胞、HT-1197细胞、HT-1197人膀胱癌细胞
Part of: BLA-40 bladder carcinoma cell line panel.
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Part of: MD Anderson Cell Lines Project.
Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
Part of: UBC-40 urothelial bladder cancer cell line index.
Population: Caucasian.
Doubling time: 61 hours (PubMed=3708594); 46 hours (PubMed=25984343).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: shRNA library screening.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
上海酶研生物科技有限公司
品牌商实名认证
钻石会员
入驻年限:10年